|
1
|
Seto E, Yang L, Middeldorp J, Sheen TS,
Chen JY, Fukayama M, Eizuru Y, Ooka T and Takada K: Epstein-Barr
virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal
carcinoma and EBV-associated gastric carcinoma tissues in the
absence of lytic gene expression. J Med Virol. 76:82–88. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Y, Ohyashiki JH, Takaku T, Shimizu N
and Ohyashiki K: Transcriptional profiling of Epstein-Barr virus
(EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and
chronic active EBV infection. Br J Cancer. 94:599–608. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Q, Tsao SW, Ooka T, Nicholls JM,
Cheung HW, Fu S, Wong YC and Wang X: Anti-apoptotic role of BARF1
in gastric cancer cells. Cancer Lett. 238:90–103. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takada K: Epstein-Barr virus and gastric
carcinoma. Mol Pathol. 53:255–261. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Klein E: The complexity of the
Epstein-Barr virus infection in humans. Pathol Oncol Res. 4:3–7.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rowe M, Lear AL, Croom-Carter D, Davies AH
and Rickinson AB: Three pathways of Epstein-Barr virus gene
activation from EBNA1-positive latency in B lymphocytes. J Virol.
66:122–131. 1992.PubMed/NCBI
|
|
7
|
zur Hausen A, Brink AA, Craanen ME,
Middeldorp JM, Meijer CJ and van den Brule AJ: Unique transcription
pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric
adenocarcinomas: Expression of the transforming BARF1 gene. Cancer
Res. 60:2745–2748. 2000.PubMed/NCBI
|
|
8
|
Wei MX, de Turenne-Tessier M, Decaussin G,
Benet G and Ooka T: Establishment of a monkey kidney epithelial
cell line with the BARF1 open reading frame from Epstein-Barr
virus. Oncogene. 14:3073–3081. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sheng W, Decaussin G, Sumner S and Ooka T:
N-terminal domain of BARF1 gene encoded by Epstein-Barr virus is
essential for malignant transformation of rodent fibroblasts and
activation of BCL-2. Oncogene. 20:1176–1185. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sheng W, Decaussin G, Ligout A, Takada K
and Ooka T: Malignant transformation of Epstein-Barr virus-negative
Akata cells by introduction of the BARF1 gene carried by
Epstein-Barr virus. J Virol. 77:3859–3865. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bai L and Wang S: Targeting apoptosis
pathways for new cancer therapeutics. Annu Rev Med. 65:139–155.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Plotnikov A, Zehorai E, Procaccia S and
Seger R: The MAPK cascades: Signaling components, nuclear roles and
mechanisms of nuclear translocation. Biochim Biophys Acta.
1813:1619–1633. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Balmanno K and Cook SJ: Tumour cell
survival signalling by the ERK1/2 pathway. Cell Death Differ.
16:368–377. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ohashi M, Fogg MH, Orlova N, Quink C and
Wang F: An Epstein-Barr virus encoded inhibitor of colony
stimulating factor-1 signaling is an important determinant for
acute and persistent EBV infection. PLoS Pathog. 8:e10030952012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iyoda K, Sasaki Y, Horimoto M, Toyama T,
Yakushijin T, Sakakibara M, Takehara T, Fujimoto J, Hori M, Wands
JR and Hayashi N: Involvement of the p38 mitogen-activated protein
kinase cascade in hepatocellular carcinoma. Cancer. 97:3017–3026.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Angel P, Hattori K, Smeal T and Karin M:
The jun proto-oncogene is positively autoregulated by its product,
Jun/AP-1. Cell. 55:875–885. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meng Q and Xia Y: c-Jun, at the crossroad
of the signaling network. Protein Cell. 2:889–898. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Neyns B, Katesuwanasing, Vermeij J,
Bourgain C, Vandamme B, Amfo K, Lissens W, DeSutter P,
Hooghe-Peters E and DeGrève J: Expression of the jun family of
genes in human ovarian cancer and normal ovarian surface
epithelium. Oncogene. 12:1247–1257. 1996.PubMed/NCBI
|
|
19
|
Vleugel MM, Greijer AE, Bos R, van der
Wall E and van Diest PJ: c-Jun activation is associated with
proliferation and angiogenesis in invasive breast cancer. Hum
Pathol. 37:668–674. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Eferl R, Ricci R, Kenner L, Zenz R, David
JP, Rath M and Wagner EF: Liver tumor development. c-Jun
antagonizes the proapoptotic activity of p53. Cell. 112:181–192.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Young MR, Li JJ, Rincón M, Flavell RA,
Sathyanarayana BK, Hunziker R and Colburn N: Transgenic mice
demonstrate AP-1 (activator protein-1) transactivation is required
for tumor promotion. Proc Natl Acad Sci USA. 96:9827–9832. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eferl R, Sibilia M, Hilberg F,
Fuchsbichler A, Kufferath I, Guertl B, Zenz R, Wagner EF and
Zatloukal K: Functions of c-Jun in liver and heart development. J
Cell Biol. 145:1049–1061. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Harper SJ and LoGrasso P: Signalling for
survival and death in neurones: The role of stress-activated
kinases, JNK and p38. Cell Signal. 13:299–310. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rawal N, Parish C, Castelo-Branco G and
Arenas E: Inhibition of JNK increases survival of transplanted
dopamine neurons in Parkinsonian rats. Cell Death Differ.
14:381–383. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Adhikary G, Sun Y and Pearlman E: C-Jun
NH2 terminal kinase (JNK) is an essential mediator of Toll-like
receptor 2-induced corneal inflammation. J Leukoc Biol. 83:991–997.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ruano D, Revilla E, Gavilán MP, Vizuete
ML, Pintado C, Vitorica J and Castaño A: Role of p38 and inducible
nitric oxide synthase in the in vivo dopaminergic cells'
degeneration induced by inflammatory processes after
lipopolysaccharide injection. Neuroscience. 140:1157–1168. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin A: Activation of the JNK signaling
pathway: Breaking the brake on apoptosis. Bioessays. 25:17–24.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hilberg F, Aguzzi A, Howells N and Wagner
EF: c-jun is essential for normal mouse development and
hepatogenesis. Nature. 365:179–181. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Raitano AB, Halpern JR, Hambuch TM and
Sawyers CL: The Bcr-Abl leukemia oncogene activates Jun kinase and
requires Jun for transformation. Proc Natl Acad Sci USA.
92:11746–11750. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hess P, Pihan G, Sawyers CL, Flavell RA
and Davis RJ: Survival signaling mediated by c-Jun NH (2)-terminal
kinase in transformed B lymphoblasts. Nat Genet. 32:201–205. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Milone MR, Pucci B, Bruzzese F, Carbone C,
Piro G, Costantini S, Capone F, Leone A, Di Gennaro E, Caraglia M
and Budillon A: Acquired resistance to zoledronic acid and the
parallel acquisition of an aggressive phenotype are mediated by
p38-MAP kinase activation in prostate cancer cells. Cell Death Dis.
4:e6412013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zelivianski S, Spellman M, Kellerman M,
Kakitelashvilli V, Zhou XW, Lugo E, Lee MS, Taylor R, Davis TL,
Hauke R and Lin MF: ERK inhibitor PD98059 enhances
docetaxel-induced apoptosis of androgen-independent human prostate
cancer cells. Int J Cancer. 107:478–485. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nishinaka T, Miura T, Sakou M, Hidaka C,
Sasaoka C, Okamura A, Okamoto A and Terada T: Down-regulation of
aldo-keto reductase AKR1B10 gene expression by a phorbol ester via
the ERK/c-Jun signaling pathway. Chem Biol Interact. 234:274–281.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shaulian E and Karin M: AP-1 as a
regulator of cell life and death. Nat Cell Biol. 4:E131–E136. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li ZL, Abe H, Ueki K, Kumagai K, Araki R
and Otsuki Y: Identification of c-Jun as bcl-2 transcription factor
in human uterine endometrium. J Histochem Cytochem. 51:1601–1609.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen Y, Lian G, Zhang Q, Zeng L, Qian C,
Chen S and Huang K: Overexpression of Bmi-1 induces the malignant
transformation of gastric epithelial cells in vitro. Oncol Res.
21:33–41. 2013. View Article : Google Scholar : PubMed/NCBI
|
